PMID- 23026572 OWN - NLM STAT- MEDLINE DCOM- 20130312 LR - 20121002 IS - 1873-2623 (Electronic) IS - 0041-1345 (Linking) VI - 44 IP - 8 DP - 2012 Oct TI - New law of renal transplantation in Portugal associated with more acute rejection episodes and higher costs. PG - 2276-9 LID - S0041-1345(12)00756-7 [pii] LID - 10.1016/j.transproceed.2012.07.060 [doi] AB - The new law implemented in August 2007 changed the criteria to select renal transplantation (RT) candidates in Portugal, favoring hyperimmunized subjects and those on the waiting list for a longer time, making human leukocyte antigen (HLA) compatibilities less important. The authors compared patients who received a deceased donor kidney between 2005 and 2010. Patients were divided in group A who underwent transplantation before August 2007 (n = 132) and group B (n = 125) after that date. We considered a value of P < .05. Overall mean age at RT was 46.6 +/- 13.9 years with 58.8% men, 88% on hemodialysis (HD), with a mean dialysis time of 82.8 +/- 119 months. Also, 10.5% of patients underwent a previous transplantation. The mean follow-up was 35 +/- 17.1 months. Group B showed significant adverse differences, including dialysis time (50.9 vs. 117 months), length of hospitalization (14.4 vs. 23.2 days), need for HD (1 vs. 3.4 days), HLA match (3.3 vs. 1.4 compatibilities), previous sensitization (4.4% vs. 21.7%), acute rejection episodes in the 1st year (23% vs. 37%), greater use of immunosuppressive drugs, higher costs of induction therapy (2790 vs 4360ϵ), and greater costs of drugs during first hospitalization (3456 vs. 7144ϵ). Among the 16 subjects who lost their grafts, 7 were in group A (3 in the first year) and 9 in group B all in the first year. There was a 5.1% decrease in graft survival at 12 months (P = .07). Univariate analysis showed an association of acute rejection episodes with HLA mismatches, hyperimmunized patients, absence of immediate graft function, hospitalization time, longer HD need, and higher creatinine level at months 1, 2, 3, and 6. Multivariate analysis revealed acute rejection episodes to be associated with a lower number of HLA compatibilities (odds ratio = 0.65; 95% confidence interval, [0.46-0.9]). Application of the law has led to a greater number of acute rejection episodes in the first year and increased costs. CI - Copyright (c) 2012 Elsevier Inc. All rights reserved. FAU - Goncalves, J A AU - Goncalves JA AD - Hospital Amato Lusitano, Castelo Branco, Portugal. jpmag.med@gmail.com FAU - Jorge, C AU - Jorge C FAU - Atalaia, A AU - Atalaia A FAU - Matias, P AU - Matias P FAU - Bruges, M AU - Bruges M FAU - Birne, R AU - Birne R FAU - Dickson, J AU - Dickson J FAU - Weigert, A AU - Weigert A FAU - Machado, D AU - Machado D LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Transplant Proc JT - Transplantation proceedings JID - 0243532 RN - 0 (HLA Antigens) RN - 0 (Immunosuppressive Agents) SB - IM MH - Acute Disease MH - Adult MH - Drug Costs MH - Female MH - Graft Rejection/*economics/*etiology MH - Graft Survival MH - HLA Antigens/immunology MH - *Health Care Costs MH - Health Policy/*economics MH - Histocompatibility MH - Histocompatibility Testing/economics MH - Hospital Costs MH - Humans MH - Immunosuppressive Agents/economics/therapeutic use MH - *Kidney Transplantation/adverse effects/economics/immunology/legislation & jurisprudence MH - Length of Stay/economics MH - Linear Models MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Odds Ratio MH - *Patient Selection MH - Peritoneal Dialysis/economics MH - Portugal MH - Renal Dialysis/economics MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Time Factors MH - Treatment Outcome MH - Waiting Lists EDAT- 2012/10/03 06:00 MHDA- 2013/03/13 06:00 CRDT- 2012/10/03 06:00 PHST- 2012/10/03 06:00 [entrez] PHST- 2012/10/03 06:00 [pubmed] PHST- 2013/03/13 06:00 [medline] AID - S0041-1345(12)00756-7 [pii] AID - 10.1016/j.transproceed.2012.07.060 [doi] PST - ppublish SO - Transplant Proc. 2012 Oct;44(8):2276-9. doi: 10.1016/j.transproceed.2012.07.060.